Bessemer Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
6CM
Bessemer Group's ANAB Position: Q3 2026 in Review
Bessemer Group reduced its AnaptysBio (ANAB) stake by 1.3% in Q3 2026, selling an estimated $1.02K and leaving 1,410 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.
Bessemer Group first reported a position in ANAB in Q3 2024 and has held it in 8 quarters since. The position peaked at $96K in Q2 2026. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Bessemer Group held 1,410 shares of AnaptysBio worth $71K as of Q3 2026.
- Bessemer Group sold 18 AnaptysBio shares in Q3 2026, an estimated $1.02K.
- AnaptysBio made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1620 holding.
- Bessemer Group first reported a position in AnaptysBio in Q3 2024 and has held it in 8 quarters since.
- Bessemer Group's AnaptysBio position peaked at $96K in Q2 2026.
- 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.